The global bleeding disorders treatment market is projected to reach USD 15.09 Billion by 2021 from USD 10.33 Billion in 2016, at a CAGR of 7.9% from 2016 to 2021. The global market is broadly classified into type, drug class, and region.
Market Drivers
1 Rising R&D Investment for Development of Hemophilia Products
2 Increasing Preference for Prophylactic Treatment
3 Increasing Number of Diagnosed Hemophilia Patients
4 Increasing Healthcare Expenditure
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71198026
Market Restraints
1 High Cost of Hemophilia Drugs
2 Insufficient Reimbursement
Market Opportunities
1 Local Partnerships in Pharma-emerging Countries
2 Rising Disposable Income and Improving Healthcare Infrastructure in Developing Nations
3 Growing Biosimilar Products Market
Market Threats
1 High Entry Barriers Created By Local Government in Certain Countries
2 Low Switch Rate for Hemophilia Products
3 High Competition from Established Players
